Health Concerns Around Fluoride in Water Merit EPA Action, Judge Rules
Medically reviewed by Drugs.com.
By Robin Foster HealthDay Reporter
THURSDAY, Sept. 26, 2024 -- -- The Environmental Protection Agency must address concerns about potential health risks posed by the recommended levels of fluoride in the country's drinking water, a federal court in California has ruled.
While District Court Judge Edward Chen was careful to note his decision "does not conclude with certainty that fluoridated water is injurious to public health," he added that evidence of its potential risk was now enough that the EPA has to do something.
"In all, there is substantial and scientifically credible evidence establishing that fluoride poses a risk to human health; it is associated with a reduction in the IQ of children and is hazardous at dosages that are far too close to fluoride levels in the drinking water of the United States," Chen wrote in his ruling, which was issued Tuesday.
The decision fuels the growing debate about whether the benefits of adding fluoride to the water supply outweigh its potential harms.
For nearly a decade, anti-fluoride groups have been fighting in the courts over fluoridated drinking water. The nonprofit Food & Water Watch is the petitioner in the California case.
Chen's ruling cited a recent review by the National Institutes of Health's toxicology program that concluded "higher levels" of fluoride are linked to lowered IQ in children.
But last month, the American Academy of Pediatrics challenged the validity of the NIH review, saying other reports have come to different conclusions about fluoride's risks and benefits.
Meanwhile, the U.S. Centers for Disease Control and Prevention continues to endorse the addition of fluoride to drinking water as one of the greatest public health achievements in recent history.
While the NIH report did say that more research was needed to assess the potential dangers of the lower levels of fluoride typically found in U.S. drinking water, Chen ruled "there is not enough of a margin" of safety at those levels.
He pointed to studies of pregnant moms that found their fluoride exposure could be even higher. EPA experts had told the court those higher levels could be due to exposure to fluoride in food, toothpaste and other dental products.
"Not only is there an insufficient margin between the hazard level and these exposure levels, for many, the exposure levels exceed the hazard level," Chen noted in his ruling.
Chen left it up to the EPA to decide exactly what action to take -- that could be anything from warning labels about fluoride's risks at current levels to tightening restrictions on its addition to drinking water.
"One thing the EPA cannot do, however, in the face of this Court's finding, is to ignore that risk," Chen wrote.
"From our vantage point, the obvious way of eliminating the risk from adding fluoride chemicals to drinking water is to stop adding them," Michael Connett, the lead attorney for the groups who brought the lawsuit, told CBS News.
The judge's ruling stems from a lawsuit first brought by the anti-fluoride groups under a 2016 chemical safety law that allowed them to challenge the EPA in court after the agency denied their petition.
"Clearly, the length of time the judge took to decide this case shows that the court did not rush to make this decision. It took its time, it allowed extensive testimony and evidence. So it was certainly not a rush job, just the opposite of it," Connett said.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-09-27 00:00
Read more
- Multiple Chronic Conditions Can Add Up to Kidney Trouble
- GLP-1 RAs Reduce Risk for Clinically Important Kidney, CVD Outcomes
- Chatbot "Brains" May Slow with Age
- Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Second Fast Track Designation from FDA for Treatment of Triple Negative Breast Cancer (TNBC)
- Inflammatory Bowel Disease on the Rise Globally in the Elderly
- FDA Approves Yesintek (ustekinumab-kfce), a Biosimilar to Stelara
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions